Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Irritable Bowel Syndrome - Constipation”

153 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 153 results

Large-scale testing (Phase 3)Ended earlyNCT00171431
What this trial is testing

The Effect of Tegaserod on Patterns of Flow in the Small Bowel of Patients With Irritable Bowel Syndrome (IBS)

Who this might be right for
Constipation PredominantIrritable Bowel Syndrome (IBS-C)
Novartis Pharmaceuticals 20
Not applicableUnknownNCT05646186
What this trial is testing

Personalized Dietary Intervention Based on Microbiome Analysis vs FODMAP Diet for Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome With DiarrheaIrritable Bowel Syndrome With Constipation+1 more
Istanbul Medipol University Hospital 100
Not applicableLooking for participantsNCT04918329
What this trial is testing

Functional Digestive Disorders Observatory

Who this might be right for
Irritable Bowel SyndromeDyspepsiaFunctional Constipation+3 more
University Hospital, Rouen 2,000
Post-approval studies (Phase 4)Study completedNCT01886781
What this trial is testing

Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
University of Stellenbosch 81
Testing effectiveness (Phase 2)Study completedNCT01149200
What this trial is testing

Proof-of-Principle Study of TC-6499 in the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Bowel Syndrome
Targacept Inc. 24
Not applicableEnrolling By InvitationNCT06837064
What this trial is testing

Efficacy of Chatbot for Irritable Bowel Syndrome (IBS) Patients

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome - ConstipationIrritable Bowel Syndrome - Diarrhoea+1 more
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 54
Large-scale testing (Phase 3)UnknownNCT04757493
What this trial is testing

The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 160
Not applicableStudy completedNCT03150212
What this trial is testing

Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C Phenotype

Who this might be right for
Constipation-predominant Irritable Bowel Syndrome
Lesaffre International 456
Large-scale testing (Phase 3)Study completedNCT00731679
What this trial is testing

Rifaximin 3 Times/Day (TID) for Non-Constipation Irritable Bowel Syndrome (IBS)

Who this might be right for
Non-Constipation Irritable Bowel Syndrome
Bausch Health Americas, Inc. 623
Testing effectiveness (Phase 2)Study completedNCT01728610
What this trial is testing

Effect of Probiotic Supplement in Alleviating Functional Gastrointestinal Symptoms

Who this might be right for
Irritable Bowel Syndrome
Danisco 391
Testing effectiveness (Phase 2)Study completedNCT00583128
What this trial is testing

Safety and Efficacy of AST-120 in Patients With Non-Constipating Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Ocera Therapeutics 117
Not applicableStudy completedNCT04968652
What this trial is testing

IBS-C Questionnaire Study

Who this might be right for
Irritable Bowel Syndrome With ConstipationFunctional Constipation
AstraZeneca 300
Testing effectiveness (Phase 2)Study completedNCT00460811
What this trial is testing

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Who this might be right for
Irritable Bowel Syndrome With Constipation
Ironwood Pharmaceuticals, Inc. 420
Testing effectiveness (Phase 2)Study completedNCT02082457
What this trial is testing

Efficacy and Safety of YKP10811 in Subjects With Irritable Bowel Syndrome With Constipation

Who this might be right for
Irritable Bowel SyndromeConstipation
SK Chemicals Co., Ltd. 273
Not applicableStudy completedNCT05164861
What this trial is testing

Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations

Who this might be right for
Irritable Bowel Syndrome With ConstipationConstipation-predominant Irritable Bowel Syndrome
Vasily Isakov 40
Testing effectiveness (Phase 2)Study completedNCT01176227
What this trial is testing

Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS)

Who this might be right for
Irritable Bowel SyndromeDigestive System DiseasesColonic Diseases, Functional+2 more
The Canadian College of Naturopathic Medicine 128
Not applicableStudy completedNCT05157061
What this trial is testing

GOS to Reduce Symptom Severity in IBS

Who this might be right for
Irritable Bowel SyndromeIrritable Bowel Syndrome - ConstipationIrritable Bowel Syndrome - Diarrhoea+1 more
Clasado 153
Post-approval studies (Phase 4)Ended earlyNCT02837783
What this trial is testing

The Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

Who this might be right for
Irritable Bowel Syndrome Characterized by Constipation
Ironwood Pharmaceuticals, Inc. 20
Large-scale testing (Phase 3)Study completedNCT02686138
What this trial is testing

A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C

Who this might be right for
Constipation Predominant Irritable Bowel Syndrome
Ardelyx 593
Testing effectiveness (Phase 2)Study completedNCT00813098
What this trial is testing

Study of LX1031 in Subjects With Non-Constipating Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Lexicon Pharmaceuticals 155
Load More Results